Russian Heart Failure Journal 2015year Effect of L-carnitinee on echocardiographic parameters in patients with acute coronary syndrome

To access this material please log in or register

Register Authorize

Effect of L-carnitinee on echocardiographic parameters in patients with acute coronary syndrome

Glezer M. G., Kiseleva A. E., Prokofieva E. B., Astashkin E. I.
State Budgetary Educational Institution "I. M. Sechenov First Moscow State Medical University" of the RF Ministry of Health Care, Trubetskaya 8, Bldg. 2, Moscow 119991

Keywords: ACS, myocardial infarction, doppler tissue echocardiography, L-carnitine, left ventricular ejection fraction, local and global contractility, diastolic function

DOI: 10.18087/rhfj.2015.4.2153

Background. High prevalence of HF is often due to myocardial injury in ACS and postinfarction heart remodeling. Therefore, searching for ways to reduce severity of myocardial damage and postinfarction remodeling is important. Aim. To evaluate the effect of intravenous L-carnitine injection on the structural and functional condition of the heart in patients with ACS. Materials and methods. The effect of intravenous L-carnitine/placebo injection on parameters of structural and functional heart condition was studied in 58 patients with ACS during the hospital period. EchoCG parameters were studied at 1-3 days and 12-15 days of admission. Results. The L-carnitine treatment resulted in decreases of end-systolic and end-diastolic volumes (ESV and EDV) of the heart, thereby improving LV myocardial contractility, whereas the placebo treatment resulted in a less pronounced decrease in ESV and a considerable increase in EDV. The most pronounced EF changes and a significant EF response to the L-carnitine treatment were observed in patients with originally reduced EF. In the L-carnitine treatment group, tissue dopplerography showed a significant increase in peak systolic velocity of myocardial motions in different LV segments. Thus, the peak systolic velocity (Sm) of basal and medium interventricular septal (IVS) segments increased from 3.5±1.3 to 4.1±1.2 m / sec (р<0.002) and from 2.7±1.2 to 3.2±1.2 m / sec (р<0.004), respectively. Basal, medium and apical lateral wall segment Sm increased from 3.6±1.7 to 4.3±1.8 m / sec (р<0.0008), from 2.5±1.3 to 2.9±1.2 m / sec (р<0.01), and from 1.7±0.9 to 2.0±0.8 m / sec (р<0.01), respectively. Basal and medium inferior wall segment Sm also increased from 3.1±1.4 to 3.6±1.2 m/sec (р <0.006) and from 2.6±1.1 to 2.7±0.4 m/sec, respectively. No significant increases in Sm of studied LV myocardial segments were observed in the standard treatment group and in the placebo group. Conclusion. Early post-ACS intravenous L-carnitine administration reduced the pronouncement of postinfarction heart remodeling and improved parameters of myocardial contractility during hospitalization. The most pronounced response was observed in patients with reduced baseline EF.
  1. Фомин И. В., Беленков Ю. Н., Мареев В. Ю., Агеев Ф. Т., Бадин Ю. В., Галявич А. С. и др. Распространенность хронической сердечной недостаточности в Европейской части Российской Федерации – данные ЭПОХА–ХСН. Журнал Сер­дечная Недостаточность. 2006;7 (3):112–5.
  2. Асташкин Е. И. Глезер М. Г. Роль L-карнитина в энергетическом обмене кардиомиоцитов и лечении заболеваний сердечно-сосудистой системы. Кардиология и сердечно-сосудистая хирургия. 2012;5 (6):58–65.
  3. Глезер М. Г. Фармакотерапевтические мероприятия, направленные на предупреждение постинфарктного ремоделирования сердца. Фарматека. 2009;15:48–54.
  4. Глезер М. Г., Асташкин Е. И. Патогенез постинфарктного ремоделирования сердца. Часть 1. Роль ренин-ангиотензиновой системы. Клиническая геронтология. 2000;1–2:54–60.
  5. Dirksen MT, Laarman GJ, Simoons ML, Duncker DJ. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res. 2007 Jun 1;74 (3):343–55.
  6. Effect of 48‑h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project – Free Radicals. Eur Heart J. 2000 Sep;21 (18):1537–46.
  7. Spagnoli LG, Corsi M, Villaschi S, Palmieri G, Maccari F. Myocardial carnitine deficiency in acute myocardial infarction. Lancet. 1982 Jun 19;1 (8286):1419–20.
  8. Pfeffer MA, Pfeffer JM. Ventricular enlargement and reduced survival after myocardial infarction. Circulation. 1987 May;75 (5 Pt 2):IV93–7.
  9. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as a major determinant of survival after recovery from myocardial infarction. Circulation. 1987 Jul;76 (1):44–51.
  10. Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation. 1994 Jan;89 (1):68–75.
  11. Carstensen S, Bonarjee VV, Berning J, Edner M, Nilsen DW, Caidahl K. Effects of early enalapril treatment on global and regio­nal wall motion in acute myocardial infarction. CONSENSUS II Multi Echo Study Group. Am Heart J. 1995 Jun;129 (6):1101–8.
  12. Mao CY, Lu HB, Kong N, Li JY, Liu M, Yang CY, Yang P. Levocarnitine protects H9c2 rat cardiomyocytes from H2O2‑induced mitochondrial dysfunction and apoptosis. Int J Med Sci. 2014 Aug 15;11 (11):1107–15.
  13. Ura K, Hironaka Y, Sakurai I. Effect of carnitine on size limitation of experimental myocardial infarct. Am J Cardiovasc Pathol. 1990;3 (2):131–42.
  14. Liedtke AJ, DeMaison L, Nellis SH. Effects of L-propionyl-L-car­nitine on mechanical recovery during reflow in intact hearts. Am J Physiol. 1988 Jul;255 (1Pt 2):H169–76.
  15. Micheletti R, Di Paola ED, Schiavone A, English E, Benatti P, Capasso JM et al. Propionyl-L-carnitine limits chronic ventricular dilatation after myocardial infarction in rats. Am J Physiol. 1993 Apr;264 (4 Pt 2):H1111–7.
  16. Beyersdorf F, Acar C, Buckberg GD, Partington MT, Okamoto F, Allen BS et al. Studies on prolonged acute regional ischemia. V. Metabolic support of remote myocardium during left ventricular power failure. J Thorac Cardiovasc Surg. 1989 Oct;98 (4):567–79.
  17. Iliceto S, Scrutinio D, Bruzzi P, D’Ambrosio G, Boni L, Di Biase M et al. Effect of L-carnitine administration on left ventricular remo­deling after acute anterior myocardial infarction: the L–Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trial. J Am Coll Cardiol. 1995 Aug;26 (2):380–7.
  18. Iyer R, Gupta A, Khan A, Hiremath S, Lokhandwala Y. Does left ventricular function improve with L-carnitine after acute myocardial infarction? J Postgrad Med. 1999 Apr-Jun;45 (2):38–41.
  19. Najafi M. Effects of postconditioning, preconditioning and perfusion of L-carnitine during whole period of ischemia / reperfusion on cardiac hemodynamic functions and myocardial infarction size in isolated rat heart. Iran J Basic Med Sci. 2013 Apr;16 (4):648–55.
  20. Глезер М. Г., Киселева А. Е., Асташкин Е. И. Влияние L-карни­тина на дисперсию интервала QT у пациентов с острым коронарным синдромом. Кардиология. 2015;55 (3):4–9.
  21. Derumeaux G, Ovize M, Loufoua J, Andre-Fouet X, Minaire Y, Cribier A, Letac B. Doppler tissue imaging quantitates regional wall motion during myocardial ischemia and reperfusion. Circulation. 1998 May 19;97 (19):1970–7.
  22. Edvardsen T, Aakhus S, Endresen K, Bjomerheim R, Smiseth OA, Ihlen H. Acute regional myocardial ischemia identified by 2‑dimensional multiregion Doppler imaging tissue technique. J Am Soc Echocardiogr. 2000 Nov;13 (11):986–94.
  23. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler ima­ging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol. 2007 May 15;49 (19):1903–14.
  24. Richardson-Lobbedez M, Maréchaux S, Bauters C, Darchis J, Auffray Jl, Bauchart JJ et al. Prognostic importance of tissue Doppler-derived diastolic function in patients presenting with acute coronary syndrome: a bedside echocardiographic study. Eur J Echocardiogr. 2008 Sep;9 (5):594–8.
  25. Hillis GS, Ujino K, Mulvagh SL, Hagen ME, Oh JK. Echocardio­graphic indices of increased left ventricular filling pressure and dilation after acute myocardial infarction. J Am Soc Echocardiogr. 2006 Apr;19 (4):450–6.
  26. Рябова Т. Р., Соколов А. А., Рябов В. В. Возможности стресс-эхокардиографии при хронической сердечной недостаточности. Журнал Сердечная Недостаточность. 2014;15 (1):56–64.
  27. Nie Y, Chen BX, Feng XH, Li ZP, Li WH, Li L, Gao W. Prognostic values for in-hospital event rate of early E / Em in patients with acute myocardial infarction. Zhonghua Yi Xue Za Zhi. 2011 Sep;91 (34):2380–3.
  28. Broderick TL, Quinney HA, Barker CC, Lopaschuk GD. Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimu­lation of glucose oxidation. Circulation. 1993 Mar;87 (3):972–81.
  29. Nemoto S, Aoki M, Dehua C, Imai Y. Effects of carnitine on cardiac function after cardioplegic ischemia in neonatal rabbit hearts. Ann Thorac Surg. 2001 Jan;71 (1):254–9.
  30. Keller VA, Toporoff B, Raziano RM, Pigott JD, Mills NL. Carnitine supplementation improves myocardial function in hearts from ische­mic diabetic and euglycemic rats. Ann Thorac Surg. 1998 Nov;66 (5):1600–3.
  31. Serati AR, Motamedi MR, Emami S, Varedi P, Movahed MR. L-carnitine treatment in patients with mild diastolic heart failure is associated with improvement in diastolic function and symptoms. Cardiology. 2010;116 (3):178–82.
Glezer M. G., Kiseleva A. E., Prokofieva E. B., Astashkin E. I. Effect of L-carnitinee on echocardiographic parameters in patients with acute coronary syndrome. Russian Heart Failure Journal. 2015;16 (4):234–240

To access this material please log in or register

Register Authorize
Ru En